Eurofins Scientific
Search results
Jun 10, 2024 · As a mid-sized global biopharmaceutical company, Ipsen improves patients’ lives through research, innovation and the development of transformative medicines in Oncology, Rare Disease and Neuroscience. WHAT WE DO.
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on transformative medicines in three therapeutic areas: oncology, rare disease and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
Ipsen designs and manufactures industrial vacuum furnaces, atmosphere furnaces, and controls for thermal processing markets.
Learn about Ipsen, a global pharma company that aims to prolong patients’ lives, improve health outcomes and create a positive impact for patients and society.
As a mid-sized global biopharmaceutical company, Ipsen improves people’s lives through research, innovation and the development of transformative medicines in Oncology, Rare Disease and Neuroscience.
We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.
Ipsen Technologies Pvt Ltd is a 100% owned Indian subsidiary of Ipsen International, Germany. Ipsen, with wholly owned units in Germany, USA, China, Japan and India, not only enjoys the widest...
Ipsen focuses on platform products by delivering the first TITAN® vacuum and ATLAS® atmosphere standard furnaces. The PdMetrics software platform launches, which integrates with the IoT and provides predictive maintenance capabilities.
Ipsen India’s Atmosphere Technology Business continues to trend up, achieving 27 percent YOY sales growth for Atmosphere Furnaces in 2022.
Discover Ipsen's range of pharmaceutical products in the fields of oncology, neuroscience and rare disease. Developed with a commitment to improving patient outcomes across various therapeutic areas.
